Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact?
Aim. To analyze the individual association of arterial hypertension (AH) prevalence, awareness, treatment, and control with regional characteristics within the national epidemiological ESSE-RF study (2012-2022), assessing the impact of the COronaVIrus Disease 2019 (COVID-19) pandemic.Material and me...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2025-06-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/3178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839641114265518080 |
|---|---|
| author | S. A. Maksimov S. A. Shalnova Yu. A. Balanova A. E. Imaeva V. A. Kutsenko M. B. Kotova G. A. Muromtseva S. E. Evstifeeva A. V. Kapustina N. S. Karamnova O. B. Shvabskaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya O. A. Bashkina S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovieva A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova E. V. Mikhailov Yu. O. Tarabrina M. G. Ataev M. O. Radzhabov Z. M. Gasanova M. A. Umetov I. A. Hakuasheva L. V. Elgarova E. I. Yamashkina L. A. Balykova A. A. Usanova A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova V. S. Yudin A. A. Keskinov S. M. Yudin A. V. Kontsevaya O. M. Drapkina |
| author_facet | S. A. Maksimov S. A. Shalnova Yu. A. Balanova A. E. Imaeva V. A. Kutsenko M. B. Kotova G. A. Muromtseva S. E. Evstifeeva A. V. Kapustina N. S. Karamnova O. B. Shvabskaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya O. A. Bashkina S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovieva A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova E. V. Mikhailov Yu. O. Tarabrina M. G. Ataev M. O. Radzhabov Z. M. Gasanova M. A. Umetov I. A. Hakuasheva L. V. Elgarova E. I. Yamashkina L. A. Balykova A. A. Usanova A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova V. S. Yudin A. A. Keskinov S. M. Yudin A. V. Kontsevaya O. M. Drapkina |
| author_sort | S. A. Maksimov |
| collection | DOAJ |
| description | Aim. To analyze the individual association of arterial hypertension (AH) prevalence, awareness, treatment, and control with regional characteristics within the national epidemiological ESSE-RF study (2012-2022), assessing the impact of the COronaVIrus Disease 2019 (COVID-19) pandemic.Material and methods. The analysis used pooled data from the ESSE-RF study across three time periods: ESSE-RF-1 (2012-2014), ESSE-RF-2 (2017-2018), ESSERF-3 (2020-2022). The final analytical sample across all three periods 55.725 men and women aged 25-74 years. The presence, awareness, treatment and of AH were considered as individual outcomes. Regional living conditions were assessed using the "Economic", "Demographic", "Industrial" and "Social" indices based on data from the National Medical Research Center for Therapy and Preventive Medicine. Statistical analysis was performed using generalized estimating equations (logistic regression models) with calculation of Odds Ratios and 95% Confidence Intervals. To assess the impact of the COVID-19 pandemic on the associations between regional living conditions and AH prevalence, awareness, treatment, and control, separate analyses were performed in the ESSE-RF-1 2012-2014 and ESSERF-3 2020-2022 samples.Results. Improvement of social living conditions was associated with a decreased probability of AH (0.90; 0.85-0.95), increased AH treatment (1.13; 1.02-1.25), and control (1.11; 1.01-1.22). A demographic shift toward a younger age structure in regions was associated with a decreased AH probability (0.83; 0.76-0.91). Increasing industrial development in regions was associated with decreased AH treatment (0.87; 0.80-0.96). Compared to sex, age, and obesity, regional indices contributed significantly less to the studied outcomes. Nevertheless, the contribution of regional living conditions was comparable to such individual predictors as education level, income, and urban/rural residence. Substantial differences were observed in the associations between regional indices and AH treatment/control in the pre-pandemic (presence of multiple associations) and pandemic (associations virtually absent) study periods.Conclusion. The results of the study indicate associations of AH prevalence, treatment, and control with regional living conditions. The attenuation or even inversion of associations between regional characteristics and AH treatment/control during the COVID-19 period confirms the significance of the pandemic as a powerful driver of changes in individual and population health-related behavior. |
| format | Article |
| id | doaj-art-ec40beb14c9b48a6a6c84d722bf4058d |
| institution | Matheson Library |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-ec40beb14c9b48a6a6c84d722bf4058d2025-07-03T07:28:41ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532025-06-0121210811810.20996/1819-6446-2025-31782282Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact?S. A. Maksimov0S. A. Shalnova1Yu. A. Balanova2A. E. Imaeva3V. A. Kutsenko4M. B. Kotova5G. A. Muromtseva6S. E. Evstifeeva7A. V. Kapustina8N. S. Karamnova9O. B. Shvabskaya10T. V. Repkina11T. O. Gonoshilova12A. V. Kudryavtsev13N. I. Belova14L. L. Shagrov15M. A. Samotrueva16A. L. Yasenyavskaya17O. A. Bashkina18S. V. Glukhovskaya19I. A. Levina20E. A. Shirshova21E. B. Dorzhieva22E. Z. Urbanova23N. Yu. Borovkova24V. K. Kurashin25A. S. Tokareva26Yu. I. Ragino27G. I. Simonova28A. D. Khudyakova29V. N. Nikulin30O. R. Aslyamov31G. V. Khokhlova32A. V. Solovieva33A. A. Rodionov34O. V. Kryachkova35Yu. Yu. Shamurova36E. V. Mikhailov37Yu. O. Tarabrina38M. G. Ataev39M. O. Radzhabov40Z. M. Gasanova41M. A. Umetov42I. A. Hakuasheva43L. V. Elgarova44E. I. Yamashkina45L. A. Balykova46A. A. Usanova47A. M. Nikitina48N. V. Savvina49Yu. E. Spiridonova50E. A. Naumova51V. S. Yudin52A. A. Keskinov53S. M. Yudin54A. V. Kontsevaya55O. M. Drapkina56National Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineRegional Center for Public Health and Medical PreventionRegional Center for Public Health and Medical PreventionNorthern State Medical UniversityNorthern State Medical UniversityNorthern State Medical UniversityAstrakhan State Medical UniversityAstrakhan State Medical UniversityAstrakhan State Medical UniversitySverdlovsk Regional Medical CollegeSverdlovsk Regional Medical CollegeSverdlovsk Regional Medical CollegeBoyanov Center for Public Health and Medical PreventionBoyanov Center for Public Health and Medical PreventionPrivolzhsky Research Medical UniversityPrivolzhsky Research Medical UniversityPrivolzhsky Research Medical UniversityResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsOrenburg Regional Center for Public Health and Medical PreventionOrenburg Regional Center for Public Health and Medical PreventionOrenburg Regional Center for Public Health and Medical PreventionTver State Medical UniversityTver State Medical UniversityTver State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversityDagestan State Medical UniversityDagestan Federal Research Centre of the Russian Academy of SciencesDagestan State Medical UniversityBerbekov Kabardino-Balkarian State UniversityBerbekov Kabardino-Balkarian State UniversityBerbekov Kabardino-Balkarian State UniversityOgarev Mordovian State UniversityOgarev Mordovian State UniversityOgarev Mordovian State UniversityRepublican Center for Public Health and Medical PreventionAmmosov North-Eastern Federal UniversityAmmosov North-Eastern Federal UniversityRepublican Center for Public Health and Medical PreventionCenter for Strategic Planning and Management of Biomedical Health RisksCenter for Strategic Planning and Management of Biomedical Health RisksCenter for Strategic Planning and Management of Biomedical Health RisksNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineAim. To analyze the individual association of arterial hypertension (AH) prevalence, awareness, treatment, and control with regional characteristics within the national epidemiological ESSE-RF study (2012-2022), assessing the impact of the COronaVIrus Disease 2019 (COVID-19) pandemic.Material and methods. The analysis used pooled data from the ESSE-RF study across three time periods: ESSE-RF-1 (2012-2014), ESSE-RF-2 (2017-2018), ESSERF-3 (2020-2022). The final analytical sample across all three periods 55.725 men and women aged 25-74 years. The presence, awareness, treatment and of AH were considered as individual outcomes. Regional living conditions were assessed using the "Economic", "Demographic", "Industrial" and "Social" indices based on data from the National Medical Research Center for Therapy and Preventive Medicine. Statistical analysis was performed using generalized estimating equations (logistic regression models) with calculation of Odds Ratios and 95% Confidence Intervals. To assess the impact of the COVID-19 pandemic on the associations between regional living conditions and AH prevalence, awareness, treatment, and control, separate analyses were performed in the ESSE-RF-1 2012-2014 and ESSERF-3 2020-2022 samples.Results. Improvement of social living conditions was associated with a decreased probability of AH (0.90; 0.85-0.95), increased AH treatment (1.13; 1.02-1.25), and control (1.11; 1.01-1.22). A demographic shift toward a younger age structure in regions was associated with a decreased AH probability (0.83; 0.76-0.91). Increasing industrial development in regions was associated with decreased AH treatment (0.87; 0.80-0.96). Compared to sex, age, and obesity, regional indices contributed significantly less to the studied outcomes. Nevertheless, the contribution of regional living conditions was comparable to such individual predictors as education level, income, and urban/rural residence. Substantial differences were observed in the associations between regional indices and AH treatment/control in the pre-pandemic (presence of multiple associations) and pandemic (associations virtually absent) study periods.Conclusion. The results of the study indicate associations of AH prevalence, treatment, and control with regional living conditions. The attenuation or even inversion of associations between regional characteristics and AH treatment/control during the COVID-19 period confirms the significance of the pandemic as a powerful driver of changes in individual and population health-related behavior.https://www.rpcardio.online/jour/article/view/3178arterial hypertensionepidemiologytreatmenttreatment adherencedisease awarenessrussian regionsliving conditionsesse-rf |
| spellingShingle | S. A. Maksimov S. A. Shalnova Yu. A. Balanova A. E. Imaeva V. A. Kutsenko M. B. Kotova G. A. Muromtseva S. E. Evstifeeva A. V. Kapustina N. S. Karamnova O. B. Shvabskaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya O. A. Bashkina S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovieva A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova E. V. Mikhailov Yu. O. Tarabrina M. G. Ataev M. O. Radzhabov Z. M. Gasanova M. A. Umetov I. A. Hakuasheva L. V. Elgarova E. I. Yamashkina L. A. Balykova A. A. Usanova A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova V. S. Yudin A. A. Keskinov S. M. Yudin A. V. Kontsevaya O. M. Drapkina Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? Рациональная фармакотерапия в кардиологии arterial hypertension epidemiology treatment treatment adherence disease awareness russian regions living conditions esse-rf |
| title | Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? |
| title_full | Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? |
| title_fullStr | Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? |
| title_full_unstemmed | Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? |
| title_short | Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact? |
| title_sort | prevalence awareness treatment and control of arterial hypertension depending on regional characteristics in russia results of the esse rf study 2012 2022 evidence of covid 19 impact |
| topic | arterial hypertension epidemiology treatment treatment adherence disease awareness russian regions living conditions esse-rf |
| url | https://www.rpcardio.online/jour/article/view/3178 |
| work_keys_str_mv | AT samaksimov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT sashalnova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT yuabalanova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT aeimaeva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT vakutsenko prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT mbkotova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT gamuromtseva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT seevstifeeva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT avkapustina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT nskaramnova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT obshvabskaya prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT tvrepkina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT togonoshilova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT avkudryavtsev prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT nibelova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT llshagrov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT masamotrueva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT alyasenyavskaya prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT oabashkina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT svglukhovskaya prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT ialevina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT eashirshova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT ebdorzhieva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT ezurbanova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT nyuborovkova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT vkkurashin prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT astokareva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT yuiragino prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT gisimonova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT adkhudyakova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT vnnikulin prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT oraslyamov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT gvkhokhlova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT avsolovieva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT aarodionov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT ovkryachkova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT yuyushamurova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT evmikhailov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT yuotarabrina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT mgataev prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT moradzhabov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT zmgasanova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT maumetov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT iahakuasheva prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT lvelgarova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT eiyamashkina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT labalykova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT aausanova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT amnikitina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT nvsavvina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT yuespiridonova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT eanaumova prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT vsyudin prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT aakeskinov prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT smyudin prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT avkontsevaya prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact AT omdrapkina prevalenceawarenesstreatmentandcontrolofarterialhypertensiondependingonregionalcharacteristicsinrussiaresultsoftheesserfstudy20122022evidenceofcovid19impact |